Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
9 Leser
Artikel bewerten:
(0)

2016 Emerging Strategies for the German Hospital Hematology and Flow Cytometry Markets - Product Development Opportunities for Instruments, Consumables, and Auxiliary Products

DUBLIN, Oct. 27, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/mkfhbb/2016_emerging) has announced the addition of the "2016 Emerging Strategies for the German Hospital Hematology and Flow Cytometry Markets" report to their offering.

This new report contains 233 pages, 15 tables, and presents a comprehensive analysis of the German hospital hematology and flow cytometry markets, including:

Major issues pertaining to the German hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.Five-year volume and sales forecasts for major hematology and flow cytometry tests performed in German hospitals.Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and flow cytometers.Review of current instrumentation technologies, and a feature comparison of high-, medium-, and low-volume/POC analyzers.Five-year reagent and instrument sales forecasts.

Sales and market shares of leading reagent and instrument suppliers.Review of current and emerging technologies, and their potential market applications.Product development opportunities for instruments, consumables, and auxiliary products.Profiles of major current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.Business opportunities and strategic recommendations for suppliers.

Companies Mentioned

  1. Abbott
  2. Affymetrix
  3. Beckman Coulter/Danaher
  4. Becton Dickinson
  5. bioMerieux
  6. Bio-Rad
  7. Cepheid
  8. Diamedix
  9. DiaSorin
  10. Eiken Chemical
  11. Elitech Group
  12. Enzo Biochem
  13. Fujirebio
  14. Grifols
  15. Hologic/Gen-Probe
  16. ID Biomedical/GSK
  17. Kreatech/Leica
  18. Lonza
  19. Ortho-Clinical Diagnostics
  20. Qiagen
  21. Roche
  22. Scienion
  23. Sequenom
  24. SeraCare
  25. Siemens
  26. Takara Bio
  27. Thermo Fisher/Life Technology
  28. Wallac/PE
  29. Wako

For more information visit http://www.researchandmarkets.com/research/mkfhbb/2016_emerging

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2015 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.